Bioinformatics and Genomics Programme, Centre for Genomic Regulation (CRG) and UPF, Doctor Aiguader, 88, Barcelona, 08003, Spain.
BMC Genomics. 2013 Sep 14;14:623. doi: 10.1186/1471-2164-14-623.
Candida glabrata follows C. albicans as the second or third most prevalent cause of candidemia worldwide. These two pathogenic yeasts are distantly related, C. glabrata being part of the Nakaseomyces, a group more closely related to Saccharomyces cerevisiae. Although C. glabrata was thought to be the only pathogenic Nakaseomyces, two new pathogens have recently been described within this group: C. nivariensis and C. bracarensis. To gain insight into the genomic changes underlying the emergence of virulence, we sequenced the genomes of these two, and three other non-pathogenic Nakaseomyces, and compared them to other sequenced yeasts.
Our results indicate that the two new pathogens are more closely related to the non-pathogenic N. delphensis than to C. glabrata. We uncover duplications and accelerated evolution that specifically affected genes in the lineage preceding the group containing N. delphensis and the three pathogens, which may provide clues to the higher propensity of this group to infect humans. Finally, the number of Epa-like adhesins is specifically enriched in the pathogens, particularly in C. glabrata.
Remarkably, some features thought to be the result of adaptation of C. glabrata to a pathogenic lifestyle, are present throughout the Nakaseomyces, indicating these are rather ancient adaptations to other environments. Phylogeny suggests that human pathogenesis evolved several times, independently within the clade. The expansion of the EPA gene family in pathogens establishes an evolutionary link between adhesion and virulence phenotypes. Our analyses thus shed light onto the relationships between virulence and the recent genomic changes that occurred within the Nakaseomyces.
Nakaseomyces delphensis: CAPT01000001 to CAPT01000179Candida bracarensis: CAPU01000001 to CAPU01000251Candida nivariensis: CAPV01000001 to CAPV01000123Candida castellii: CAPW01000001 to CAPW01000101Nakaseomyces bacillisporus: CAPX01000001 to CAPX01000186.
光滑念珠菌是继白念珠菌之后全球第二或第三大常见的念珠菌血症病原体。这两种致病性酵母菌亲缘关系较远,光滑念珠菌属于 Nakaseomyces,该群与酿酒酵母关系更为密切。虽然此前认为 Nakaseomyces 中只有光滑念珠菌一种致病菌,但最近又在该群中描述了两种新的病原体:尼瓦瑞念珠菌和布拉氏念珠菌。为了深入了解毒力出现的基因组变化,我们对这两种新病原体以及其他三种非致病性 Nakaseomyces 进行了基因组测序,并与其他已测序的酵母菌进行了比较。
我们的结果表明,这两种新病原体与非致病性 N. delphensis 的亲缘关系比与光滑念珠菌更为密切。我们发现了特定于包含 N. delphensis 和三个病原体的分支之前的谱系的基因重复和加速进化,这可能为该谱系感染人类的更高倾向性提供了线索。最后,Epa 样黏附素的数量在病原体中特异性富集,尤其是在光滑念珠菌中。
值得注意的是,一些被认为是光滑念珠菌适应致病性生活方式的结果的特征,在整个 Nakaseomyces 中都存在,这表明这些特征是对其他环境的古老适应。系统发育表明,人类发病机制在该分支内独立进化了多次。病原体中 EPA 基因家族的扩张为黏附和毒力表型之间建立了进化联系。我们的分析因此揭示了 Nakaseomyces 内发生的毒力与最近基因组变化之间的关系。
Nakaseomyces delphensis:CAPT01000001 至 CAPT01000179 念珠菌布拉氏菌:CAPU01000001 至 CAPU01000251 念珠菌尼瓦瑞:CAPV01000001 至 CAPV01000123 念珠菌 Castellii:CAPW01000001 至 CAPW01000101 Nakaseomyces bacillisporus:CAPX01000001 至 CAPX01000186。